SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

UNITED HYDROGEN GLOBAL INC.
Date: Sept. 12, 2025 · CIK: 0002032241 · Accession: 0000000000-25-009949

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284430

Date
September 12, 2025
Author
Division of
Form
UPLOAD
Company
UNITED HYDROGEN GLOBAL INC.

Letter

Re: United Hydrogen Global Inc. United Hydrogen Group Inc. Amended Registration Statement on Form F-4 Filed September 12, 2025 File No. 333-284430 Dear Xia Ma and Xia Ma:

September 12, 2025

Xia Ma Chief Executive Officer United Hydrogen Global Inc. 3rd Floor, Building 3, No. 715 Yingshun Road Qingpu District, Shanghai The People s Republic of China, 201799

Xia Ma Director United Hydrogen Group Inc. 3rd Floor, Building 3, No. 715 Yingshun Road Qingpu District, Shanghai The People s Republic of China, 201799

We have reviewed your amended registration statement and have the following comments.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. September 12, 2025 Page 2

Amendment No. 4 to Form F-4 Dilution to the Shareholders of Aimei Health, page 183

1. Please update your dilution table, here and on page 34, to reflect Aimei Health's updated financial information as of June 30, 2025. Refer to Item 1604(c) of Regulation S-K. Exhibits

2. We note the assumption number 5 that "the sole director and shareholders of the Company have not taken any steps to have the Company struck off or placed in liquidation..." It is not appropriate for counsel to include in its opinion assumptions that assume any of the material facts underlying the opinion. Please revise this assumption or explain. Refer to Section II.B.3.a of Staff Legal Bulletin No. 19. 3. Please reconcile the tax opinion filed as Exhibit 8.1, which states that "the exchange of Purchaser Ordinary Shares for Pubco Class A Ordinary Shares, pursuant to the Transactions, should qualify as part of an exchange governed by Sections 351(a) and 368(a) of the Code" with the disclosure on page 172 that the transactions "will" qualify as an exchange. Please also revise the disclosure beginning on page 174 to clearly reflect the opinion of Hunter Taubman Fischer & Li as it relates to Section 368(a) of the Code. Please contact Eric McPhee at 202-551-3693 or Jennifer Monick at 202-551-3295 if you have questions regarding comments on the financial statements and related matters. Please contact Pam Howell at 202-551-3357 or Jeffrey Gabor at 202-551-2544 with any other questions.

Sincerely,
Division of
Corporation Finance
Office of Real
Estate & Construction
cc: Meng (Mandy) Lai, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 September 12, 2025

Xia Ma
Chief Executive Officer
United Hydrogen Global Inc.
3rd Floor, Building 3, No. 715 Yingshun Road
Qingpu District, Shanghai
The People s Republic of China, 201799

Xia Ma
Director
United Hydrogen Group Inc.
3rd Floor, Building 3, No. 715 Yingshun Road
Qingpu District, Shanghai
The People s Republic of China, 201799

 Re: United Hydrogen Global Inc.
 United Hydrogen Group Inc.
 Amended Registration Statement on Form F-4
 Filed September 12, 2025
 File No. 333-284430
Dear Xia Ma and Xia Ma:

 We have reviewed your amended registration statement and have the
following
comments.

 Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

 After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.
 September 12, 2025
Page 2

Amendment No. 4 to Form F-4
Dilution to the Shareholders of Aimei Health, page 183

1. Please update your dilution table, here and on page 34, to reflect Aimei
Health's
 updated financial information as of June 30, 2025. Refer to Item 1604(c)
of
 Regulation S-K.
Exhibits

2. We note the assumption number 5 that "the sole director and shareholders
of the
 Company have not taken any steps to have the Company struck off or
placed in
 liquidation..." It is not appropriate for counsel to include in its
opinion assumptions
 that assume any of the material facts underlying the opinion. Please
revise this
 assumption or explain. Refer to Section II.B.3.a of Staff Legal Bulletin
No. 19.
3. Please reconcile the tax opinion filed as Exhibit 8.1, which states that
"the exchange
 of Purchaser Ordinary Shares for Pubco Class A Ordinary Shares, pursuant
to the
 Transactions, should qualify as part of an exchange governed by Sections
351(a) and
 368(a) of the Code" with the disclosure on page 172 that the
transactions "will"
 qualify as an exchange. Please also revise the disclosure beginning on
page 174 to
 clearly reflect the opinion of Hunter Taubman Fischer & Li as it relates
to Section
 368(a) of the Code.
 Please contact Eric McPhee at 202-551-3693 or Jennifer Monick at
202-551-3295 if
you have questions regarding comments on the financial statements and related
matters. Please contact Pam Howell at 202-551-3357 or Jeffrey Gabor at
202-551-2544 with
any other questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Real
Estate & Construction
cc: Meng (Mandy) Lai, Esq.
</TEXT>
</DOCUMENT>